BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2026 1:21:59 PM | Browse: 1 | Download: 0
 |
Received |
|
2026-01-13 10:34 |
|
Peer-Review Started |
|
2026-01-13 10:34 |
|
First Decision by Editorial Office Director |
|
2026-01-20 06:07 |
|
Return for Revision |
|
2026-01-20 06:07 |
|
Revised |
|
2026-02-04 14:27 |
|
Publication Fee Transferred |
|
2026-02-11 02:58 |
|
Second Decision by Editor |
|
2026-03-10 02:50 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-10 07:07 |
|
Articles in Press |
|
2026-03-10 07:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-15 02:45 |
|
Publish the Manuscript Online |
|
2026-05-27 13:21 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of serum aldo-keto reductase family 1 member B10 in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun-Ling Du, Chang-Jiang Shi, Fang-Yuan Gao, Shou-Jun Xie, Meng-Na Zhang, Zhu-Qing Zhang, Wei Qiu and Ying Ming |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Science and Technology Program of Chengde |
202109A064 |
|
| Corresponding Author |
Ying Ming, Department of Laboratory Medicine, The Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi Street, Shuangqiao District, Chengde 067000, Hebei Province, China. 18503145756@163.com |
| Key Words |
Hepatocellular carcinoma; Aldo-keto reductase family 1 member B10; Prognosis; Serum biomarker; Molecular biomarkers |
| Core Tip |
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Despite recent improvements in diagnostic approaches and surgical techniques, the five-year survival rate for patients with advanced HCC remains low, largely due to the absence of early clinical symptoms and the lack of reliable diagnostic and prognostic biomarkers. Over the past decade, aldo–keto reductase family 1 member 10 (AKR1B10) has emerged as a potential biomarker for both the diagnosis and prognosis of HCC. This study aimed to investigate the correlation between serum AKR1B10 Levels and prognosis in patients with HCC, evaluate its clinical value as a prognostic indicator, and provide a theoretical basis and research direction for individualized treatment strategies. |
| Publish Date |
2026-05-27 13:21 |
| Citation |
Du YL, Shi CJ, Gao FY, Xie SJ, Zhang MN, Zhang ZQ, Qiu W, Ming Y. Prognostic value of serum aldo-keto reductase family 1 member B10 in hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(5): 116672 |
| URL |
https://www.wjgnet.com/1948-9366/full/v18/i5/116672.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v18.i5.116672 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
